Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759898 | 1.00 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL77521 | 1.00 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Triacetin SCHEMBL22160048 | 0.98 | PRKCA (0.57) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Acetic Acid SCHEMBL8675242 | 0.96 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Ethylene Glycol SCHEMBL16612582 | 0.96 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Isopropyl Alcohol SCHEMBL11286605 | 0.94 | PRKCA (0.54) | PRKCATDP1 | |
| SCHEMBL17707870 | 0.92 | PRKCA (0.53) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Propylene Glycol SCHEMBL20138436 | 0.92 | PRKCA (0.53) | PRKCATDP1 | |
| Glycerin SCHEMBL4461415 | 0.92 | PRKCA (0.53) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Triacetin SCHEMBL9802800 | 0.92 | PRKCA (0.57) | PRKCATDP1PRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116115772-A | Construction and application of core-shell structure nanoparticle for targeted elimination of antigen-specific T cells | 浙江大学 | 2023-05-16 | — | — | CN | claimed |
| CN-116115772-B | Construction and application of core-shell structure nanoparticle for targeted elimination of antigen-specific T cells | 浙江大学 | 2025-06-17 | — | — | CN | disclosed |
| CN-119317440-A | Methods of treating leukocytosis, endothelial dysfunction and cardioflammatory using lipid binding protein-based complexes | 阿比奥尼克斯制药公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-118845708-A | Preparation method and application of multifunctional bionic delivery platform capable of efficiently crossing mucosa disorder and inducing mucosa immunity enhancement | 大连理工大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118829625-A | Novel ionizable lipids and lipid nanoparticles and methods of use thereof | 赛欧生物医药股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024098361-A1 | ARTIFICIAL NUCLEIC ACID MOLECULE | 斯微(上海)生物科技股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| CN-116997326-A | Strategies for developing genomic editing Spherical Nucleic Acids (SNAs) | 西北大学 | 2023-11-03 | — | — | CN | disclosed |
| CN-116115772-A | Construction and application of core-shell structure nanoparticle for targeted elimination of antigen-specific T cells | 浙江大学 | 2023-05-16 | — | — | CN | disclosed |
| CN-114441765-A | System and method for protein corona sensor array for early detection of disease | 布里格姆及妇女医院股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114441747-A | System and method for protein corona sensor array for early detection of disease | 布里格姆及妇女医院股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
| WO-2017102654-A1 | PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2017-06-22 | — | — | WO | disclosed |
| US-8703437-B2 | Fluorogenic sensors for phospholipase C isozymes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2014-04-22 | — | — | US | disclosed |
| US-20130183701-A1 | Fluorogenic Sensors for Phospholipase C Isozymes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-07-18 | — | — | US | disclosed |
| EP-0639586-B1 | Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them | ADIR (FR) | 2001-03-21 | — | — | EP | disclosed |
| US-5608045-A | DISODIUM SALT BY POT REACTING RHAMNOSE TRIACETATE WITH PHENYL DICHLOROPHOSPHATE IN PRESENCE OF TRIETHYLAMINE AND WITH /S/LEU-/S/TRP-OET IN SOLVENT, SAPONIFYING SEPARATED PRODUCT WITH ETHANOLIC BASE IN COLD, EVAPORATING ETHANOL | ADIR ET COMPAGNIE (FR) | 1997-03-04 | — | — | US | disclosed |
| US-5591728-A | ENZYME INHIBITORS WITH AMIDE AND ESTER GROUPS | ADIR ET COMPAGNIE (FR) | 1997-01-07 | — | — | US | disclosed |
| US-5481030-A | USED AS AN ENDOTHELIN CONVERTASE INHIBITOR | ADIR ET COMPAGNIE (FR) | 1996-01-02 | — | — | US | disclosed |
| EP-0639586-A1 | Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them | ADIR ET COMPAGNIE (FR) | 1995-02-22 | — | — | EP | disclosed |